09/30/2013
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
September 27, 2013
ANVISA alert to the risk of consumption of the syrup children with active Dextromethorphan , manufactured in Paraguay without registration in Brazil , which is causing adverse effects .
This syrup is found in Paraguay under the trade names of MENTOVICK , TEGNOGRIP PLUS , TEGNOGRIP , MEDIBRON , BRONOLEX and BRONALAR .
The record adverse situation occurred in Paraguay itself and in the border region of Ponta Pora and Pedro Juan Caballero , in the state of Mato Grosso do Sul
The side effects caused by medication are dyspnea , respiratory failure and drowsiness , which may lead to coma and death .
As a statement by the Ministry of Health of Paraguay , the drugs are banned from being sold in the country . Children who ingested the drug should be taken to a health facility .
Alert ANVISA
Alert Visa / MS
Source : ANVISA
Our news are taken in full from our partner sites . For this reason , we can not change the contents of the same even in cases of typos .
transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.